Caricamento...
Standard Operating Procedure for In-house Preparation of 131 I-rituximab for Radioimmunotherapy of Non-Hodgkin′s Lymphoma
A Standard Operating Procedure (SOP) has been formulated for in-house preparation, quality control, dispensing and administration of 131 I-rituximab appropriate for the safe, effective, radioimmunotherapy of non-Hodgkin lymphoma. A decade of experience of semi-automated radioiodination of rituximab...
Salvato in:
Autori principali: | , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Wolters Kluwer Medknow Publications
2012-07-01
|
Serie: | World Journal of Nuclear Medicine |
Soggetti: | |
Accesso online: | http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.103408 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|